Having determined that glucose increased the levels of IGFBP-2 both at the protein and mRNA levels in breast cancer cells, the role of IGFBP-2 in the response of breast cancer cells to chemotherapy was investigated. This evidence concerns the gene IGFBP2 and breast carcinoma.